SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S10 - "Best Of" Session: MS and CNS Inflammatory Disease

Event Time: Monday April 24, 2017 8:00 am to 9:00 am
Topic(s): MS and CNS Inflammatory Disease
Description: A platform session that brings together the top four scoring abstracts in a particular topic, as rated by the topic reviewers. Offers an opportunity to interact with the author in a smaller setting at the conclusion of the session.
Completion Message:
CME Credits: 1
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
8:35 AM - 8:45 AM Panel Discussion None  
8:45 AM - 9:00 AM Meet the Investigators None  


Speaker Disclosure

Abstract Presenters

Start Time Pub. Title Presenter
8:00 AM 001 Longitudinal characterization of cortical lesion evolution in multiple sclerosis by ultra high field MRI Constantina A Treaba
Dr. Treaba has nothing to disclose.

8:08 AM 002 Durable Reduction in MRI Disease Activity With Alemtuzumab in the Absence of Continuous Treatment in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Were Treatment-Naive: 6-Year Follow-up of the CARE-MS I Study Douglas L Arnold, MD
Dr. Arnold has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda, Biogen, F. Hoffmann-La Roche Ltd, MedDay, MedImmune, Mitsubishi, Novartis, Receptos/Celgene, Sanofi-Aventis. Dr. Arnold has received compensation for serving on the Board of Directors of NeuroRx Research.

8:16 AM 003 Environmental risk factors associated with pediatric MS: The role of remote viral infections and vitamin D revisited. Shayandokht Taleb, MD
Dr. Taleb has nothing to disclose.

8:24 AM 004 Self-reported fatigue and lower limb problems predictive of conversion to secondary progressive multiple sclerosis in an aging sample of patients Caila Vaughn
Dr. Vaughn has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

9:30 AM-11:30 AM
C11 Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C175 Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
1:00 PM-3:00 PM
N5 Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis Eric Klawiter MD,
Ellen Mowry MD, FAAN
3:30 PM-5:30 PM
S44 MS and CNS Inflammatory Disease Platform Session

Friday April 27, 2018

8:00 AM-9:00 AM
S47 MS and CNS Inflammatory Disease Platform Session
1:00 PM-3:00 PM
C224 Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN
S51 MS and CNS Inflammatory Disease Platform Session
3:30 PM-5:30 PM
S52 MS and CNS Inflammatory Disease Platform Session
4:30 PM-5:30 PM
Ask Us Anything: Expert Panel on Multiple Sclerosis John Rose MD, FAAN,
John Corboy MD, FAAN,
Edward Fox MD, PhD, FAAN


Forgot Password?